Compare Centene Corp (CNC) vs Huntington Bancshares Incorporated (HBAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Huntington Bancshares Incorporated — how do they compare? Centene Corp trades at $66.88 (market cap $32.05B), while Huntington Bancshares Incorporated trades at $17.8 (market cap $35.93B). The key difference: Centene Corp and Huntington Bancshares Incorporated are close in size by market cap, and Huntington Bancshares Incorporated pays a 3.49% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | HBAN | |
|---|---|---|
Market Cap | $32.05B | $35.93B |
Sector | Health | Financials |
52-Week High | $68.72 | $19.27 |
52-Week Low | $26.17 | $15.02 |
Enterprise Value | $21.10B | — |
Dividend Yield | — | 3.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene (CNC) trades at $66.56, up 1.2% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $71.00. The company reported strong Q2 2026 earnings of $2.51 per share, beating estimates, and raised its full-year EPS guidance, reflecting margin recovery and cost discipline. Revenue growth remains robust, projected to reach $202.9 billion in 2026, though net income margins are negative due to elevated medical costs.
The stock presents a value opportunity with low P/E (8.06) and P/S (0.16) ratios, but investors face risks from Medicaid membership volatility and regulatory pressures. Analyst sentiment is strongly bullish (61% buy ratings), with institutional interest growing, as seen in recent fund additions. Near-term upside is likely if cost controls sustain profitability improvements.
HBAN trades at $17.60, up 0.28% today, with a bullish technical signal from moving averages and a consensus analyst price target of $19.78. Recent Q2 2026 earnings met estimates with EPS of $0.33, supported by net interest and fee income growth. The company targets an 18-19% ROTCE by 2027, though rising deposit costs present headwinds.
The outlook is cautiously optimistic, with valuation metrics like a P/E of 13.68 appearing reasonable. Upside potential exists if revenue growth and efficiency targets are met, but risks include margin pressure from higher funding costs and mixed earnings history. Institutional sentiment is balanced with 44.68% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →
